Literature DB >> 19969397

CoMFA and molecular docking studies of benzoxazoles and benzothiazoles as CYP450 1A1 inhibitors.

Jie Pan1, Gen-Yan Liu, Jin Cheng, Xin-Jie Chen, Xiu-Lian Ju.   

Abstract

For better understanding of the molecular interactions of inhibitors with CYP450 1A1, a series of benzoxazoles and benzothiazoles were analyzed by comparative molecular field analysis (CoMFA) and molecular docking. Two conformer-based alignment strategies were employed to construct reliable CoMFA models. The best CoMFA model yielded a predictive correlation coefficient r(2)(pred) value of 0.809. Furthermore, a three-dimensional model of CYP450 1A1 was generated by homology modeling using CYP450 1A2 as a template, and docking of 48 CYP450 1A1 inhibitors into the putative binding sites of the CYP450 1A1 were studied. The results obtained from this study will be helpful in the design of potentially active CYP450 1A1 inhibitors. Copyright (c) 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19969397     DOI: 10.1016/j.ejmech.2009.11.037

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  9 in total

1.  3D-QSAR and molecular docking studies of azaindole derivatives as Aurora B kinase inhibitors.

Authors:  Ping Lan; Wan-Na Chen; Ping-Hua Sun; Wei-Min Chen
Journal:  J Mol Model       Date:  2010-08-11       Impact factor: 1.810

2.  Pkb/Akt1 mediates Wnt/GSK3β/β-catenin signaling-induced apoptosis in human cord blood stem cells exposed to organophosphate pesticide monocrotophos.

Authors:  Mahendra P Kashyap; Abhishek K Singh; Vivek Kumar; Dharmendra K Yadav; Feroz Khan; Sadaf Jahan; Vinay K Khanna; Sanjay Yadav; Aditya B Pant
Journal:  Stem Cells Dev       Date:  2012-08-16       Impact factor: 3.272

3.  Molecular docking and enzymatic evaluation to identify selective inhibitors of aspartate semialdehyde dehydrogenase.

Authors:  Amarjit Luniwal; Lin Wang; Alexander Pavlovsky; Paul W Erhardt; Ronald E Viola
Journal:  Bioorg Med Chem       Date:  2012-03-10       Impact factor: 3.641

4.  Molecular docking and 3D-QSAR study on 4-(1H-indazol-4-yl) phenylamino and aminopyrazolopyridine urea derivatives as kinase insert domain receptor (KDR) inhibitors.

Authors:  Xiaoyun Wu; Shuguang Wu; Wen-Hua Chen
Journal:  J Mol Model       Date:  2011-06-22       Impact factor: 1.810

5.  Effect of Pluchea lanceolata bioactives in LPS-induced neuroinflammation in C6 rat glial cells.

Authors:  Pooja Srivastava; Shilpa Mohanti; Dnyaneshwar Umrao Bawankule; Feroz Khan; Karuna Shanker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-10-08       Impact factor: 3.000

6.  Pyrrolo[3,2-d]pyrimidine derivatives as type II kinase insert domain receptor (KDR) inhibitors: CoMFA and CoMSIA studies.

Authors:  Xiao-Yun Wu; Wen-Hua Chen; Shu-Guang Wu; Yuan-Xin Tian; Jia-Jie Zhang
Journal:  Int J Mol Sci       Date:  2012-02-22       Impact factor: 6.208

Review 7.  Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date.

Authors:  Jayalakshmi Sridhar; Navneet Goyal; Jiawang Liu; Maryam Foroozesh
Journal:  Molecules       Date:  2017-07-08       Impact factor: 4.411

Review 8.  Insights on cytochrome p450 enzymes and inhibitors obtained through QSAR studies.

Authors:  Jayalakshmi Sridhar; Jiawang Liu; Maryam Foroozesh; Cheryl L Klein Stevens
Journal:  Molecules       Date:  2012-08-03       Impact factor: 4.411

Review 9.  Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors.

Authors:  Zbigniew Dutkiewicz; Renata Mikstacka
Journal:  Bioinorg Chem Appl       Date:  2018-07-25       Impact factor: 7.778

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.